Guidelines for lowering lipids to reduce coronary artery disease risk: A comparison of rosuvastatin with atorvastatin, pravastatin, and simvastatin for achieving lipid-lowering goals

American Journal of Cardiology

Volumn 91, Issue 5 SUPPL. 1, 2003, Pages 11-17

  Shepherd, James ^a   Hunninghake, Donald B ^b   Barter, Philip ^c   McKenney, James M ^d   Hutchinson, Howard G ^e   Davidson, Michael H ^f  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b UNIVERSITY OF MINNESOTA   (United States)

^c ROYAL ADELAIDE HOSPITAL   (Australia)

^d National Clinical Research Inc   (United States)

^e ASTRAZENECA   (United Kingdom)

^f Royal Infirmary ^*

Author keywords

[No Author keywords available]

Indexed keywords

ANTILIPEMIC AGENT; ATORVASTATIN; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PRAVASTATIN; ROSUVASTATIN; SIMVASTATIN; TRIACYLGLYCEROL;

ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; GLYCEROL BLOOD LEVEL; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; PRACTICE GUIDELINE; PRIORITY JOURNAL; STATISTICAL ANALYSIS; TREATMENT INDICATION; TREATMENT OUTCOME;

EID: 0037422072     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(03)00004-3     Document Type: Conference Paper

References (0)